hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 21:22:20 - browse：145

A clipboard with checklist on blue dark background. -- health tech coverage from STAT — Adobe

A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with.

Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software. The startup’s leaders and investors tell STAT they’re betting that their medical knowledge, agility, and willingness to co-develop features with customers makes it a more attractive long term option than Nuance, which Microsoft says is currently used by most U.S. hospitals.

Microsoft, Abridge and other startups like Suki, Corti and Nabla are locked in a race to ease provider burnout by automating clinical note taking, and — thanks to generative AI — organizing the data in a way that could improve care, such as suggesting topics for follow-up, simplifying billing or analyzing trends at the broader patient population level.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： A virus, fished out of a lake, may have saved a man’s life

WSS

Why age limits for politicians are a terrible idea

FDA rejects Alnylam's heart disease treatment over insufficient data

AI can decode, harness the power of the humane immune system

Case highlights the risks of experimental stem cell therapy

When women are denied an abortion, their children fare worse than peers

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

leisure time

hotspot

Wikipedia

How one medical school became remarkably diverse

AI can decode, harness the power of the humane immune system

BioMarin wins approval for gene therapy to treat hemophilia A

Bill would stop addiction treatment from triggering child abuse inquiry

What does generative AI mean for health care? We asked experts

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Continuity nursing helped my family in our darkest PICU moments

HIV vaccine remains elusive. Immunologists keep trying new ideas

Hollywood unions extend contract negotiations for actors

Was Amgen transparent enough on FDA's concern on cancer drug?

focus

What to expect at HLTH 2023, the health care industry conference

Addiction experts warn against a second 'war on drugs'

Sana to lay off nearly a third of staff, de

Helping hospitals and community health centers plan for resilience

Chemotherapy drug shortage eases slightly but still widespread

Senate panel eyes new effort on drug shortages

knowledge

hotspot

hotspot

leisure time